gevilon uno comprimés pelliculés
pfizer ag - gemfibrozilum - comprimés pelliculés - gemfibrozilum 900 mg, silica colloidalis anhydrica, silicii dioxidum praecipitatum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.68 mg, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, simethiconum, talcum, macrogolum 6000, e 171, pro compresso obducto. - troubles du métabolisme des lipides - synthetika
retsevmo 40 mg gélules
eli lilly (suisse) sa - selpercatinibum - gélules - capsule: selpercatinibum 40 mg, cellulosum microcristallinum, silica colloidalis anhydrica, matériel de la capsule: gelatina, e 171, e 172 (nigrum), encre: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula. - ret-fusionspositives nicht-kleinzelliges lungenkarzinom (nsclc), ; ret-fusionspositives schilddrüsenkarzinom,; ret-mutantes medulläres schilddrüsenkarzinom - synthetika
retsevmo 80 mg gélules
eli lilly (suisse) sa - selpercatinibum - gélules - capsule: selpercatinibum 80 mg, cellulosum microcristallinum, silica colloidalis anhydrica, matériel de la capsule: gelatina, e 171, e 133, encre: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula. - ret-fusionspositives nicht-kleinzelliges lungenkarzinom (nsclc), ; ret-fusionspositives schilddrüsenkarzinom,; ret-mutantes medulläres schilddrüsenkarzinom - synthetika
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agents antinéoplasiques - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
jaypirca
eli lilly nederland b.v. - pirtobrutinib - lymphome, cellule du manteau - inhibiteurs de protéines kinases - treatment of mantle cell lymphoma (mcl).
retevmo capsule
loxo oncology inc - selpercatinib - capsule - 40mg - selpercatinib 40mg - antineoplastic agents
retevmo capsule
loxo oncology inc - selpercatinib - capsule - 80mg - selpercatinib 80mg - antineoplastic agents
uptravi 1000 mcg 60 comprimits recoberts
uptravi 1200 mcg 60 comprimits recoberts
uptravi 1400 mcg 60 comprimits recoberts